Early research (Phase 1)Study completedNCT01848340
What this trial is testing
Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16